stockrowRhythm Pharmaceuticals, Inc.
RYTM Healthcare Biotechnology
Rhythm Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $189.8 million, up 45.8% from fiscal 2024.
- Revenue
- +79.6%
- EPS
- +26.9%
- Free cash flow
- +95.4%
Quarter to September 2026, against a year earlier
Follow RYTM
Alert me
Rhythm Pharmaceuticals, Inc. (RYTM) Gross margin
Rhythm Pharmaceuticals, Inc.'s gross margin over the twelve months to 30 September 2026 was 88.2%, down 1.5 percentage points from fiscal 2025 (89.7%). Over the past ten years it has ranged from 0.00% (fiscal 2020) to 91.0% (fiscal 2022); the current reading is higher than 90% of that period. That is above the Biotechnology industry median of 65.2% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 89.7% | 0.00 |
| FY2024 | 89.7% | 1.74 |
| FY2023 | 88.0% | (2.99) |
| FY2022 | 91.0% | 9.97 |
| FY2021 | 81.0% | 81.01 |
| FY2020 | 0.00% | 0.00 |
| FY2019 | 0.00% | 0.00 |
| FY2018 | 0.00% | 0.00 |
| FY2017 | 0.00% | 0.00 |
| FY2016 | 0.00% | — |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 86.8% | (0.68) |
| Jun 2026 | 87.5% | (0.62) |
| Mar 2026 | 88.1% | (3.52) |
| Dec 2025 | 91.6% | 2.33 |
| 24 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| ARWR Arrowhead Pharmaceuticals, Inc. compare | 100.0% |
| PRAX Praxis Precision Medicines, Inc. compare | 100.0% |
| CORT Corcept Therapeutics Incorporated compare | 98.5% |
| IONS Ionis Pharmaceuticals, Inc. compare | 98.2% |
| AXSM Axsome Therapeutics, Inc. compare | 93.3% |
| RYTM Rhythm Pharmaceuticals, Inc. | 88.2% |
| ORKA Oruka Therapeutics, Inc. compare | 0.00% |
| CYTK Cytokinetics, Incorporated compare | 0.00% |
| ABVX Abivax SA Sponsored ADR compare | 0.00% |
| Biotechnology industry median | 65.2% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on RYTM
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement